Keywords: Merck & Co, Johnson & Johnson, McNeil, Consumer, OTC joint venture, USA, Canada

Merck & Co to bank $175 million on selling its share of consumer JV with Johnson & Johnson

Article | 29 September 2011

Print This

US drug giant Merck & Co (NYSE: MRK) said yesterday that it has sold its 50% interest in the Johnson & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in